To further explore and confirm the role of ZNF692 in ccRCC, we collected 58 pairs of cancer and paracancer samples from ccRCC patients (the patient information is listed in Table SI) and performed IHC analysis using an anti-ZNF692 antibody. Here, ZNF692 is linked to nonpapillary renal cell carcinoma.